Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 9, 2020Proceedings of the National Academy of SciencesOpen Access

BCG vaccine protection from severe coronavirus disease 2019 (COVID-19)

View Full Paper
Ask AI
Bookmark
Share

Authors

LELuis E. EscobarVirginia TechAMAlvaro Molina-CruzNational Institutes of HealthCBCarolina Barillas‐MuryNational Institute of Allergy and Infectious Diseases

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Escobar et al. (2020) studied this question.

synapsesocial.com/papers/69dbfc0c9e12f2ae65684098https://doi.org/10.1073/pnas.2008410117
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Making wider use of the world's most widely used vaccine: Bacille Calmette–Guérin revaccination reconsidered2013 · 90 citations
  2. 2The Efficacy of Bacillus Calmette-Guerin Vaccination of Newborns and Infants in the Prevention of Tuberculosis: Meta-Analyses of the Published Literature1995 · 697 citations
  3. 3Protection by BCG Vaccine Against Tuberculosis: A Systematic Review of Randomized Controlled Trials2013 · 1,009 citations
  4. 4The BCG World Atlas: A Database of Global BCG Vaccination Policies and Practices2011 · 596 citations
  5. 5Randomized Trial of BCG Vaccination at Birth to Low-Birth-Weight Children: Beneficial Nonspecific Effects in the Neonatal Period?2011 · 589 citations